Steven J. Burton
President chez ProMetic BioSciences Ltd.
Profil
Steven J.
Burton is currently the President & Chief Scientific Officer at Astrea Bioseparations Ltd.
and the President at ProMetic BioSciences Ltd.
He previously served as the Chief Executive Officer at Liminal BioSciences, Inc.
Postes actifs de Steven J. Burton
| Sociétés | Poste | Début |
|---|---|---|
ProMetic BioSciences Ltd.
 ProMetic BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services ProMetic BioSciences Ltd. operates as a biopharmaceutical company. The company was founded by Christopher Robin Low and is headquartered in Laval, Canada. | President | - |
Astrea Bioseparations Ltd.
 Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | President | 14/06/2021 |
Anciens postes connus de Steven J. Burton
| Sociétés | Poste | Fin |
|---|---|---|
| LIMINAL BIOSCIENCES INC. | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LIMINAL BIOSCIENCES INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ProMetic BioSciences Ltd.
ProMetic BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services ProMetic BioSciences Ltd. operates as a biopharmaceutical company. The company was founded by Christopher Robin Low and is headquartered in Laval, Canada. | Commercial Services |
Astrea Bioseparations Ltd.
Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
